Presence isn’t performance: Why most EHR messaging falls short of true trigger-based intelligence

In the U.S. health care ecosystem, few ideas have gained as much traction — and as much unquestioned acceptance — as programmatic messaging within electronic health records (EHRs). Positioned as the gateway to point-of-care (POC) engagement, it promises precision, scale and relevance at the exact moment clinical decisions are made.

Yet beneath this promise lies a growing disconnect.

What is widely described as “in-workflow” and “data-driven” often falls short of true trigger-based intelligence. As investment in this space accelerates, the gap between perceived sophistication and actual capability is becoming increasingly difficult to ignore.

Defining true trigger-based intelligence

At its core, true trigger-based intelligence is the ability to deliver messaging in direct response to real-time clinical events — where patient context, physician action and timing converge to create a meaningful moment of decision.

It is not defined by the presence of data, but by their interpretation. Rather than reacting to isolated signals, it requires evaluating multiple inputs simultaneously — diagnoses, procedures, treatment history, patient attributes and behavioral patterns — within a defined clinical window.

This distinction is consequential. While many systems operate on singular triggers, genuine intelligence emerges when signals are understood collectively, allowing engagement to align not just with relevance but with intent.

For instance, identifying a patient newly diagnosed with a condition, recently tested and yet to begin treatment, represents a fundamentally different opportunity than broad, diagnosis-based targeting. Broad targeting sees the diagnosis. Trigger-based intelligence sees the moment.

The illusion of being ‘in-workflow’

The assumption that visibility within an EHR equates to workflow integration is deeply flawed.

Most current approaches operate adjacent to care delivery rather than within it. Messages may appear during clinical activity but are rarely synchronized with the actions that define it. The result is presence without participation.

A physician navigating a patient record is not simply a member of a segment. They are engaging with a specific, evolving clinical scenario. Messaging that does not reflect this complexity risks becoming peripheral — visible, but disconnected from decision-making.

From signals to scenarios

Much of today’s targeting still rests on single-variable logic.

Targeting based on a diagnosis code, specialty or past prescribing behavior can improve efficiency, but it does not capture the multidimensional nature of clinical care. Real-world decision-making is shaped by the interplay of comorbidities, procedures, treatment pathways and patient-specific factors.

Genuine intelligence operates at the level of clinical scenarios, not isolated signals. It requires systems capable of interpreting layered conditions — where diagnosis, procedures, medications and patient attributes intersect dynamically. This moves beyond static “if-then” frameworks toward continuous evaluation, where relevance is recalibrated as new clinical actions occur.

Achieving this level of precision is not an incremental enhancement to existing programmatic models. It reflects a fundamentally different foundation — one built on direct integration with clinical systems and access to real-time data flows.

Timing as a determinant of relevance

Context is only half the equation; timing decides whether it matters.

Clinical intent is perishable. It forms at a precise point in the care process and begins to fade almost as quickly as it appears. Messaging built on last quarter’s segments is aimed at where intent was, not where it is — and by the time it lands, the moment that gave it meaning has often passed.

Clinical workflows unfold as a sequence of decisions, from intake and diagnostics to diagnosis and prescribing, each carrying a different level of intent. True trigger-based intelligence is built to read these inflection points and meet them as they occur — when a diagnosis is confirmed, when a treatment pathway is under consideration or when a prescription is being written — rather than after the fact.

By contrast, approaches dependent on delayed data or preconfigured rules frequently deliver messages that are directionally correct but temporally misaligned. In a clinical setting, this distinction is decisive.

Beyond probabilistic models

The industry’s continued reliance on probabilistic targeting further limits precision.

Much of what is positioned as advanced today remains rooted in inference — predicting behavior based on historical patterns or third-party data. While scalable, these models operate at a remove from actual clinical activity.

Trigger-based intelligence begins where inference ends. It is grounded in observable actions within the care process, enabling engagement that reflects what is occurring, rather than what is assumed.

Most existing frameworks were not designed to operate at this depth of clinical integration, which is why they default to approximation rather than true responsiveness.

Expanding the definition of context

The most advanced approaches extend this scenario-reading beyond the patient and physician to the competitive context — recognizing shifts in prescribing behavior and the moments when a treatment decision is genuinely in play. This is not a separate capability, but the same intelligence applied more broadly: Relevance is shaped not only by the clinical situation in front of the physician but by the treatment landscape surrounding it.

The role of automation

All of this surfaces a practical limit: The more clinical signals a system must weigh, the less feasible it becomes to manage them by hand.

Manually configuring rules that account for multiple conditions, treatment pathways and evolving data inputs is inherently limited. It slows execution and constrains adaptability, particularly in environments where relevance is time-sensitive.

True trigger-based systems, therefore, depend on automated interpretation and activation capabilities that reduce the gap between insight and engagement and allow strategies to evolve in step with clinical activity.

Redefining the standard

For years, access to EHR environments has been treated as a proxy for effectiveness. That assumption is no longer sufficient.

The next phase of POC engagement will be defined by intelligence, i.e., by the ability to interpret complex clinical scenarios, align with real decision points and respond in real time. Early indications suggest that only a limited set of approaches is beginning to operate at this level.

This is not a universal evolution. It is a structural shift that will differentiate those equipped to deliver true trigger-based intelligence from those constrained by legacy frameworks.

In a landscape where clinician attention is limited and expectations are rising, presence alone carries diminishing value. Precision, timing and contextual depth are emerging as the new baseline — and presence, on its own, will no longer pass for performance.

As the founder and global CEO of Doceree, Harshit Jain, M.D., has been driving health transformation, delivering creative, life-changing solutions addressing health care affordability. As CEO, his vision and goal are to address the acute problem of rising health care costs by bringing efficiency to communications with health care professionals. For his work at Doceree, he was named Elite Disruptor 2020 by PM360 and was one of the 40 Under 40 honorees for Medical Marketing and Media’s 2021 class.